News Biosimilar versions of anti-TNF drugs could save NHS money, drug company claims BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5337 (Published 06 October 2015) Cite this as: BMJ 2015;351:h5337 Article Related content Metrics Responses Peer review Related articles Observations The travesty of expensive insulin Published: 02 June 2016; BMJ 353 doi:10.1136/bmj.i2933 See more GPs enter dispute with NHS England over contract imposition BMJ April 18, 2024, 385 q904; DOI: https://doi.org/10.1136/bmj.q904 Partha Kar: We need to level up all staff, not level down doctors BMJ April 18, 2024, 385 q892; DOI: https://doi.org/10.1136/bmj.q892 Can a worker cooperative model of social care improve the patient experience and reduce pressure on GPs? BMJ April 18, 2024, 385 q783; DOI: https://doi.org/10.1136/bmj.q783 Improving dementia diagnosis will be “litmus test” of integrated care systems, says think tank BMJ April 18, 2024, 385 q872; DOI: https://doi.org/10.1136/bmj.q872 Almost a quarter more working adults will have major illness by 2040, experts predict BMJ April 17, 2024, 385 q889; DOI: https://doi.org/10.1136/bmj.q889 Cited by... The travesty of expensive insulinFulltext PDF
